NovoPath's Medical Advisory Board
Built by Pathology People Means
Built With Pathology People.
NovoPath was founded on a simple idea: the best software for pathology labs is designed by the people who actually run them. Our Medical Advisory Board is how we keep that idea real thirty years in.
The board is made up of practicing pathologists, informaticists, and lab leaders who shape our product roadmap, pressure-test our assumptions, and tell us when we’ve drifted from what labs actually need. They aren’t a symbolic panel. They are the people we call before we build.
30+
Years in pathology
300+
Labs running on NovoPath
99.9%
Uptime on Microsoft Azure cloud infrastructure
Dr. Alicia Carter
Dr. Alicia Carter is a pathologist and healthcare technology leader specializing in cytopathology, digital health transformation, laboratory operations, and clinical informatics. A practicing pathologist with over twenty years of clinical experience in gynecological pathology and cytopathology, Dr. Carter bridges the gap between complex laboratory operations and cutting-edge digital solutions.
Most recently, as Vice President of the LIMS Modernization effort at Labcorp, she partnered closely with development and implementation teams to successfully deliver a custom-built histology and cytology LIMS application. In this role, she also played a pivotal part in steering the enterprise transition to digital surgical pathology and cytology. Prior to her leadership in clinical informatics, Dr. Carter provided technical and scientific oversight for the anatomic pathology operations within a major commercial laboratory.
Dr. Carter is board-certified in Anatomic & Clinical Pathology, Cytopathology, and Clinical Informatics.
Dr. Marilyn Bui
Dr. Bui is American Board of Pathology certified in anatomic, clinical and cytopathology. She is a tenured senior member/professor in Departments of Pathology and Machine Learning at Moffitt Cancer Center & Research Institute in Tampa, FL. USA. She is Scientific Director of Analytic Microscopy Core and Chair of Women in Oncology Executive Board.
Dr. Bui is also an accomplished leader in pathology. She served as past President of Digital Pathology Association (DPA), Moffitt Medical Staff, Chinese American Pathologists Association (CAPA), and Florida Society of Pathologists (FSP). She chaired Publications Committee, CAP Today Editorial Board, Digital and Computational Pathology Committee of College of American Pathologists (CAP). She is Vice Speaker of House of Delegates and ex-officio member of Board of Governors of CAP, and board member of DPA, FSP, and Society for Imaging Informatics in Medicine.
Her clinical and research expertise includes bone and soft tissue pathology, cytopathology, biomarker testing (especially breast cancer), digital pathology, and AI. A patient-centered pathologist, Dr. Bui integrates research, education, advocacy, and service to deliver the highest standard of care, and received 2019 CAP Distinguished Patient Care Award. She is an award-winning educator, mentor, and past fellowship program director. She led the development of two major, innovative educational initiatives: Precision Medicine Academy of FSP and Digital Anatomic Pathology Academy of DPA. She actively organizes pathology meetings with DPA, ASC, USCAP, and FSP. A recognized thought leader, she has served as a study pathologist on multiple research grants and authored over 245 peer-reviewed publications, 35 book chapters, and three books. She holds three patents in digital pathology and cancer diagnostics and serves on multiple scientific advisory boards.
Dr. Bui advocates the critical role of pathology in precision medicine and has been featured in journals, podcasts, media outlets, and a documentary film on Her2Know.com.
Dr. Anuradha V. Singhal
Dr. Anuradha V. Singhal is an AP/CP board-certified pathologist with more than 20 years of experience in diagnostic pathology, laboratory medicine, and executive healthcare leadership. As a physician leader at Inform Diagnostics, she combines clinical excellence with business acumen to lead high-performing laboratory operations while advancing quality, innovation, and patient-centered care.
Throughout her career, Dr. Singhal has successfully led initiatives focused on quality management systems, operational excellence, process improvement, accreditation readiness, physician engagement, and regulatory compliance. Her expertise spans complex pathology operations, digital pathology workflows, laboratory governance, and performance improvement, with a steadfast commitment to ensuring accurate, timely diagnoses that improve patient outcomes.
Known for her analytical mindset and meticulous attention to detail, Dr. Singhal excels at solving complex pathology-related challenges through critical thinking, data-driven decision-making, and collaborative leadership. She is recognized for building strong multidisciplinary partnerships while balancing clinical excellence with operational efficiency and fiscal responsibility.
A passionate advocate for continuous improvement, Dr. Singhal is dedicated to advancing laboratory medicine through innovation, strategic leadership, quality, and a culture of excellence that benefits patients, physicians, and healthcare organizations alike.
